Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants

NCT00636285 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Sepsis

Interventions

DRUG: Placebo
DRUG: BSYX-A110
DRUG: BSYX-A110

Sponsor

Biosynexus Incorporated